NASH and NAFLD (Nonalcoholic Steatohepatitis / Nonalcoholic Fatty Liver Disease) Research

NASH and NAFLD (Nonalcoholic Steatohepatitis / Nonalcoholic Fatty Liver Disease) Research

In addition to a multidisciplinary approach to weight loss and risk factor modification, targeted treatment specific for each individual patient remains our goal. We collaborate at every level — from genetics to experimental therapeutics/clinical trials to behavior modification — to offer you a comprehensive plan for the management of fatty liver disease.

We also work in close partnership with the Institute of Genomic Medicine as an area of focus within the Precision Medicine Initiative. 

To learn more about specific research studies or clinical trials for which you may qualify, please contact our research office.

M. Cristina Falo, Ph.D.

Director of Clinical Transplant Research / CLDT Research Initiative
622 W. 168th Street, PH 11 Rm 460
New York, New York 10032
General Office: 212.305.3839
Direct Line: 212.305.6758
Fax: 212.305.6873
Email: cf2427@cumc.columbia.edu

Samina Munir

Clinical Research Coordinator
622 West 168th Street, PH 11 Rm 460
New York, New York 10032
Phone: 212.305.3839
Fax: 212.305.6873
Email: sm3417@cumc.columbia.edu

Julia Wattacheril, MD, MPH

Assistant Professor of Medicine
Center for Liver Disease and Transplantation
Columbia University - NY Presbyterian Hospital
622 West 168th Street, PH 14 105-D
New York, New York 10032
Academic Office: 212.305.0660
Appointment Scheduling: 212.305.0914
Fax: 212.305.9139

Specialty Area(s)

Trial Location

Columbia University Medical Center
622 West 168th Street
New York, NY 10032
United States